氨溴索、酚妥拉明、多巴酚丁胺治疗肺心病顽固性心衰疗效观察

Ambroxol,Phentolamine,Dobutamine Treatment of Pulmonary Heart Disease,Refractory Heart Failure Patients

目的:探讨氨溴索,酚妥拉明,多巴酚丁胺联合治疗肺心病顽固性心衰的临床疗效。方法:选择综合治疗加合理应用强心剂利尿剂为对照组与综合治疗加用氨溴索,酚妥拉明,多巴酚丁胺为治疗组的对比治疗。结果:治疗组对缓解临床症状,改善肺心功能明显优于对照组。结论:此方案对治疗肺心病顽固性心衰是一种较为有效的方案,较好地改善患者的生活质量,降低死亡率。

Objective： To investigate the ambroxol, phentolamine, dobutamine treating pulmonary heart disease clinical efficacy of refractory heart failure.Methods：A comprehensive treatment and a reasonable application of cardiac, diuretic and comprehensive treatment for the control group plus ambroxol, phentolamine, doqa- tincture treatment group compared amine treatment.Results：The treatment group on the clinical symptoms, changes in heart and lung function than the control group.Conelusions：The program on the treatment of refractory heart failure with pulmonary heart disease is a more effective program. And improved quality of life of patients and reduced mortality.